Search Results 521-530 of 38063 for Two-phase

1. Soft Tissue Sarcoma Clinical Trials - Mayo Clinic Research

   Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...

2. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of WSD0922-FU - Mayo Clinic

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with recurrent ...

3. An Expansion Study to Evaluate Dose Escalation, Safety and Tolerability of SAR444881 in Patients with Advanced Solid Tumors - Mayo Clinic

   Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

4. Chagas disease - Symptoms & causes - Mayo Clinic

   During the first phase of infection, treatment of Chagas disease aims to kill the parasite. ... 2, 2024. Parasites — American trypanosomiasis ... Accessed Feb 2, ...

5. Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza - Mayo Clinic

   This randomized, open-label, multicenter phase 2 trial will assess the safety, efficacy, and pharmacokinetics (PK) of anti-influenza plasma in subjects with ...

6. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... two highly effective methods of birth control for at ... Phase 1 Part 1 Expansion (Cohort 1E), Phase 1 Part 2 (Cohorts 2A, 2B), and Phase 2 Part 2 only:.

7. Phase 2a Open-Label Pilot Study Of VTX2735 In Recurrent Pericarditis - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

8. Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) - Mayo Clinic

   Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

9. Phase 3 Study of Vimseltinib for Tenosynovial Giant Cell Tumor - Mayo Clinic

   The study consists of two parts. In Part 1, eligible study participants will be assigned to receive either vimseltinib or matching placebo for 24 weeks. A ...

10. Mayo Clinic First to Show Virotherapy is Promising Against Multiple Myeloma (pkg)

    Two patients in the study received a single intravenous dose of ... More of the MV-NIS therapy is being manufactured for a larger, phase 2 clinical trial.